Stocksengineer

🌬️ Inox Wind: Riding India’s Renewable Energy Boom with Record-Breaking Growth 💡 Introduction: Powering the Future of Clean Energy Inox Wind Limited (IWL) has emerged as one of the top players in India’s wind energy sector , driving the country’s renewable energy revolution. With a blockbuster Q1 FY26 performance and a 3.1 GW order backlog (providing 2 years of revenue visibility), the company is positioned for unprecedented growth . As one of the only two integrated wind energy solution providers in India, Inox Wind is uniquely placed to benefit from: Government’s renewable energy push Rising corporate sustainability goals Growing demand for clean energy from industrial and commercial users 📊 Financial Performance: Consistent Growth Momentum 🚀 Key Q1 FY26 Highlights Revenue: ₹863 crore (+32% YoY) EBITDA: ₹220 crore (+39% YoY) PAT: ₹97 crore (+134% YoY despite ₹40 crore deferred tax) Cash PAT: ₹186 crore (+168% YoY) ⚡ Execution & Margins MW exe...

🌬️ Suzlon Energy Stock Analysis 2025 – Bullet-Point Breakdown 💡 Introduction: Suzlon’s Revival Once debt-ridden, Suzlon has staged a major turnaround. From near-collapse → to a leaner, efficient wind energy leader . Current share price: ₹57 (down from 52-week high of ₹86). Key investor question: Buy opportunity or value trap? Analysis covers: financials, order book, valuations, risks, and outlook. ⚡ Financial Resurgence – Q1 FY26 Quarterly Performance: Revenue: ₹3,132 cr (+55% YoY). EBITDA: ₹599 cr (+62% YoY); margin 19.1% . PAT: ₹324 cr (+7% YoY, moderated by tax charges). Operational Strength: WTG deliveries: 444 MW (+62% YoY). Forging division revenue: ₹146.5 cr (+60% YoY). Higher utilization = better operating leverage. 📊 Trend Table (Q1 FY26 vs Q1 FY25): Revenue ↑ 55% EBITDA ↑ 62% PAT ↑ 7% Margins ↑ 82 bps 📈 Order Book & Growth Levers Order backlog: 5.7 GW (visibility for 2–3 years). Client mix: PSUs + C&I corporates → diver...

🚀 Tata Steel Q1FY26: Strong Start, Bigger Battles Ahead — Can Momentum Last? 1️⃣ Big Picture: A Strong Quarter with Caution in the Air Tata Steel has kicked off FY26 with a solid operating performance, driven by strong domestic steel pricing and a much-improved European showing. But as the second half looms, all eyes are on demand recovery, cost tailwinds, and a delicate global market. CMP: ₹158 | Target Price: ₹177 (Upside potential: ~12%) Rating: Accumulate Market Cap: ₹1.97 lakh crore 52-Week Range: ₹123 – ₹170 💡 Sentiment Snapshot : Investor Sentiment: Moderately Bullish 📈 Analyst Sentiment: Optimistic, but pricing pressure in Q2 could test conviction Market Mood: Cautiously Positive — short-term volatility, long-term opportunity 2️⃣ Q1FY26 Highlights That Matter 🏆 Strong Pricing, Resilient Margins TSI (India) EBITDA rose 5% YoY despite a 4% drop in volumes due to planned shutdowns. Average realization jumped to ₹65,293/t , up 6.3% QoQ on post-M...

🚀 Delhivery Q1 FY26: Resilient Growth, Strategic Moves & The Next Big Leap in Logistics 📌 Introduction – The Logistics Giant Shifts Gears Delhivery, India’s leading integrated logistics player, has kicked off FY26 with a resilient performance that signals strength in its B2C express business and Partial Truck Load (PTL) segment . While short-term challenges like seasonal slowdown and marketplace insourcing loom, Delhivery is leveraging network reliability, new growth vectors , and the Ecom Express acquisition to shape a stronger, more diversified future. 1️⃣ Performance Highlights – Numbers That Matter Revenue Growth : ₹23bn in Q1 FY26, up 6% YoY . Core Drivers : Express Parcel : +10% YoY revenue, driven by 14% volume growth despite a 3% decline in per-parcel realization. PTL : +17% YoY, with tonnage up 15% YoY and realization/ton up 2%. Profitability : EBITDA Margin : 6.5% – 179 bps higher than consensus . PAT : ₹910mn, +67% YoY . Market Position : 25% e...

Thyrocare Technologies: India’s Diagnostics Dynamo with ₹1,400 Target! 🚀 (+16% Upside) 📢 Q1FY26 Blowout Triggers Re-Rating Buzz India’s diagnostics market is heating up—and Thyrocare Technologies (NSE: THYROCAR) just threw gasoline on the fire. Its Q1FY26 earnings crushed Street estimates with 23% YoY revenue growth and a 400-bps jump in EBITDA margin . With volumes soaring and parent API Holdings scaling PharmEasy synergies , analysts now peg the stock’s fair value at ₹1,400 , implying 16% upside from current levels. Here’s why Thyrocare is rapidly emerging as a long-term compounder in healthcare diagnostics. 🔍 1. Q1FY26 Results: A Diagnostic Breakthrough 📊 Key Financial Highlights Revenue : ₹1,930 million, up 23% YoY (beat estimates by 3.3%) Volume Growth : +15% YoY in test/sample count Realization per Sample : +8% YoY (driven by premium and wellness test upsell) EBITDA Margin : Jumped to 33% (up 400 bps YoY) PAT : ₹442 million, +64% YoY (beat estimates by 42...

🔷 Title: 📈 HCL Technologies Q1 FY26: Navigating Choppy Margins, Betting Big on GenAI for the Next Tech Supercycle 🔶 🔹 Introduction – The Silent Build-up to a Tech Renaissance HCL Technologies, India’s IT powerhouse, has delivered a Q1 FY26 performance that feels like a pause before a pivot . Revenue held steady, but margins slipped. Meanwhile, management is playing the long game— deepening investments in GenAI, engineering-first digital strategy, and intelligent infrastructure . But what does this mean for investors in 2025–26? Is this a temporary grind or the setup for a breakout? Let’s break it down — numbers, sentiment, forecasts, and expert advice included. 🔷 1️⃣ Performance in Focus: The Good, The Bad & The Build-Up 💡 What Worked: 🔹 Revenue at ₹30,349 Cr — inline (▲8.2% YoY, ▲0.3% QoQ) 🔹 Digital services and engineering-driven businesses kept the top line healthy. 🔹 Interim dividend of ₹12/share—still rewarding shareholders amidst transition. 💣 What ...